#ExpertAnswers: Edward Bahnson on Light-sheet Fluorescence Microscopy and Vascular Injury
This episode of #ExpertAnswers features Dr. Edward Bahnson, Assistant Professor in the Department of Cell Biology and Physiology at the University of North Carolina at Chapel Hill. Recently Dr. Bahnson joined us to talk about his lab’s development and validation of a methodological approach using light-sheet fluorescence microscopy (LSFM) for the imaging of preclinical models of vascular injury with a focus of minimizing analysis bias while increasing precision and reproducibility.
For more information or to watch the webinar, click here.
Associated Webinar: Old Dogs Benefit From New Tricks: 3D Analysis of Arterial Injury to Study Nrf2-Dependent Inhibition of Neointimal Hyperplasia in Rats
#ExpertAnswers: Artur Federowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Federowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
#ExpertAnswers: Phil Griffiths on Telemetry Studies
Phil Griffiths draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
#ExpertAnswers: Cole McLarty, Nick Glover, and Tim Hacker on Pressure-Volume Loops
Cole McLarty, Nick Glover and Dr. Timothy Hacker focus on Pressure-Volume Loop collection and data analysis for cardiovascular research.
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval Exercise
Dr. Bert Bond and Max Weston will present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.